Tilray Brands, Inc. TLRY
We take great care to ensure that the data presented and summarized in this overview for Tilray Brands, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding TLRY
View all-
Toroso Investments, LLC Massapequa, NY29MShares$27.5 Million0.09% of portfolio
-
ETF Managers Group, LLC Summit, NJ7.6MShares$7.22 Million0.69% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.55MShares$5.28 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.47MShares$4.25 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA4.42MShares$4.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.14MShares$3.93 Million0.0% of portfolio
-
Ubs Group Ag3.42MShares$3.25 Million0.0% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL3.34MShares$3.17 Million0.0% of portfolio
-
State Street Corp Boston, MA2.53MShares$2.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.44MShares$2.32 Million0.0% of portfolio
Latest Institutional Activity in TLRY
Top Purchases
Top Sells
About TLRY
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers, oils, vapes, edibles, and topicals; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, P'tite Pof, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Insider Transactions at TLRY
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 31
2025
|
Denise M Faltischek Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
49,782
-5.69%
|
$0
$0.58 P/Share
|
Jul 31
2025
|
Denise M Faltischek Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
93,928
+9.7%
|
$0
$0.58 P/Share
|
Jul 31
2025
|
Mitchell Gendel Global General Counsel |
BUY
Open market or private purchase
|
Direct |
6,000
+0.85%
|
$0
$0.58 P/Share
|
Jul 31
2025
|
Mitchell Gendel Global General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
49,782
-6.71%
|
$0
$0.58 P/Share
|
Jul 31
2025
|
Mitchell Gendel Global General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
93,928
+11.24%
|
$0
$0.58 P/Share
|
Jul 31
2025
|
Carl A Merton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
49,782
-5.13%
|
$0
$0.58 P/Share
|
Jul 31
2025
|
Carl A Merton Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
93,928
+8.83%
|
$0
$0.58 P/Share
|
Jul 31
2025
|
Irwin D Simon President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
374,295
-7.2%
|
$0
$0.58 P/Share
|
Jul 31
2025
|
Irwin D Simon President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
706,216
+11.96%
|
$0
$0.58 P/Share
|
Jul 30
2025
|
Denise M Faltischek Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
138,433
-15.06%
|
$0
$0.61 P/Share
|
Jul 30
2025
|
Denise M Faltischek Chief Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
261,194
+22.13%
|
$0
$0.61 P/Share
|
Jul 30
2025
|
David F Clanachan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
65,921
-27.83%
|
$0
$0.61 P/Share
|
Jul 30
2025
|
David F Clanachan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
124,378
+34.43%
|
$0
$0.61 P/Share
|
Jul 30
2025
|
David G. Hopkinson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
124,378
+27.04%
|
$0
$0.61 P/Share
|
Jul 30
2025
|
Thomas P. Looney Director |
BUY
Exercise of conversion of derivative security
|
Direct |
124,378
+25.98%
|
$0
$0.61 P/Share
|
Jul 30
2025
|
Johann Michael Herhalt Director |
SELL
Payment of exercise price or tax liability
|
Direct |
65,921
-27.48%
|
$0
$0.61 P/Share
|
Jul 30
2025
|
Johann Michael Herhalt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
124,378
+34.14%
|
$0
$0.61 P/Share
|
Jul 30
2025
|
Irwin D Simon President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
623,528
-12.18%
|
$0
$0.61 P/Share
|
Jul 30
2025
|
Irwin D Simon President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,176,467
+18.69%
|
$0
$0.61 P/Share
|
Jul 30
2025
|
Carl A Merton Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
88,276
-9.15%
|
$0
$0.61 P/Share
|
Last 12 Months Summary
Exercise of conversion of derivative security | 5.3M shares |
---|---|
Open market or private purchase | 231K shares |
Payment of exercise price or tax liability | 2.69M shares |
---|